Free Trial

Nautilus Biotechnology (NAUT) SEC Filings & 10K Form

Nautilus Biotechnology logo
$1.71 -0.06 (-3.39%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$1.71 0.00 (0.00%)
As of 01/31/2025 05:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Nautilus Biotechnology SEC Filings

DateFilerForm TypeView
01/31/2025
8:06 PM
Nautilus Biotechnology (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
01/31/2025
4:15 PM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:21 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
3:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
3:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:31 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
4:28 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:38 AM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
3:25 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
5:29 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2024
3:58 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
5:32 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:40 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/17/2024
3:47 PM
Nautilus Biotechnology (Issuer)
Suzuki Kentaro (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:22 PM
Godwin Mary E. (Reporting)
Nautilus Biotechnology (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
5:02 PM
EDELMAN JOSEPH (Reporting)
Nautilus Biotechnology (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:03 PM
ALTMAN MICHAEL SETH (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
5:09 PM
McIlwain Matthew S (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:37 PM
Epperly Melissa B, (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:40 PM
Akinsanya Karen (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:24 PM
Nautilus Biotechnology (Issuer)
NAZEM FARZAD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
4:35 PM
Nautilus Biotechnology (Issuer)
Pande Vijay Satyanand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2024
3:12 PM
Nautilus Biotechnology (Filer)
Form ARS
03/11/2024
7:21 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
6:06 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
11:15 PM
Nautilus Biotechnology (Filer)
Form EFFECT
03/05/2024
3:52 PM
Nautilus Biotechnology (Issuer)
Patel Sujal M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:42 PM
Mowry Anna (Reporting)
Nautilus Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:25 AM
Nautilus Biotechnology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
6:26 AM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:15 AM
Nautilus Biotechnology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:03 AM
Nautilus Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:04 AM
Nautilus Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAUT) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners